Transcatheter aortic valve replacement: is anesthesiologic management linked to surgical outcomes?

Abstract

Aortic valve replacement (AVR) is the current standard treatment for severe aortic stenosis, nonetheless, many patients are not suitable to AVR because of high risk related to advanced age, impaired cardiac function, or comorbidities. Given these considerations, transcatheter aortic valve replacement or implantation (TAVR or TAVI) has emerged in the last decade as an alternative to surgery and has become the treatment of choice for severe aortic stenosis in patients with prohibitive surgical risk. In the context of this kind of hybrid procedure, the anesthesiologist plays a central role because the choice of anesthetic technique is strongly related to clinical features of the patients and technical considerations, which must be discussed collegially with the surgeons. The choice of anesthesiologic management is different among hospitals, but it is generally based on preoperative comorbidities, procedural approach used for TAVR and even hospital logistic. Some centers used to perform TAVR under general anesthesia (GA), some else under local anesthesia plus sedation (LAS), some of them start their TAVR program under GA, but convert in LAS when the team get enough experience. Also, anesthesiologists involved in TAVR procedures must be part of a “heart team”, and should be confident with anesthesia for cardiovascular surgery, mechanical circulatory support, and with transesophageal echocardiography. The aim of this article is to provide a general overview about anesthetic techniques in TAVR and to evaluate pathways for future researches.

Keywords

Transcatheter aortic valve implantation / anesthesia / aortic valve disease

References

[1] Iung B,Butchart EG,Gohlke-Bärwolf C,Tornos P,Vermeer F,Ravaud P.A prospective survey of patients with valvular heart disease in Europe: the euro heart survey on valvular heart disease.Eur Heart J2003;24:1231-43

[2] Oppizzi M.Echocardiography in the perioperative decision making of patients with aortic stenosis.HSR Proc Intensive Care Cardiovasc Anesth2009;1:7-15 PMCID:PMC3484534

[3] Carabello BA.Aortic stenosis.Lancet2009;373:956-66

[4] Cribier A,Bash A,Tron C,Derumeaux G,Laborde F.Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description.Circulation2002;106:3006-8

[5] Nishimura RA,Bonow RO,Erwin JP3rd,O'Gara PT,Skubas NJ,Sundt TM3rd,ACC/AHA Task Force Members ACC.2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American heart association task force on practice guidelines.Circulation2014;129:2440-92

[6] Webb JG.Current status of transcatheter aortic valve replacement.J Am Coll Cardiol2012;60:483-92

[7] Leon MB,Williams M,Smith C,Schwartz A,Moses JW.Transcatheter aortic valve replacement in patients with critical aortic stenosis: rationale, device descriptions, early clinical experiences, and perspectives.Semin Thorac Cardiovasc Surg2006;18:165-74

[8] Latsios G,Grube E.Transaortic transcatheter aortic valve implantation: a novel approach for the truly "no-access option" patients.Catheter Cardiovasc Interv2010;75:1129-36

[9] Johansson M,Kimblad PO,Olivecrona GK.Transapical versus transfemoral aortic valve implantation: a comparison of survival and safety.Ann Thorac Surg2011;91:57-63

[10] Moynagh AM,Baumbach A,Brecker SJ,Brown S,Saravanan D,Teehan S,Trivedi U,Bhabra MS,Morgan KP.CoreValve transcatheter aortic valve implantation via the subclavian artery: comparison with the transfemoral approach.J Am Coll Cardiol2011;57:634-5

[11] Mack MJ,Brindis R,Edwards F,Shahian D,Peterson ED,Hewitt K,Michaels J,Christian A,Holmes D.Outcomes following transcatheter aortic valve replacement in the United States.JAMA2013;310:2069-77

[12] Greenbaum AB,Paone G,Wyman JF,Lederman RJ.Caval-aortic access to allow transcatheter aortic valve replacement in otherwise ineligible patients: initial human experience.J Am Coll Cardiol2014;63:2795-804 PMCID:PMC4105161

[13] Mylotte D,Teiger E,Lee M,Khamis H,Delhaye C,Koussa M,Piazza N.Transcarotid transcatheter aortic valve replacement: feasibility and safety.JACC Cardiovasc Interv2016;9:472-80

[14] Ree RM,Schwarz SK.Case series: anesthesia for retrograde percutaneous aortic valve replacement--experience with the first 40 patients.Can J Anaesth2008;55:761-8

[15] Behan M,Hutchinson N,Laborde JC.Percutaneous aortic valve implants under sedation: our initial experience.Catheter Cardiovasc Interv2008;72:1012-5

[16] Billings FT4th,Shanewise JS.Transcatheter aortic valve implantation: anesthetic considerations.Anesth Analg2009;108:1453-62

[17] Basciani RM.Percutaneous aortic valve implants under sedation: our initial experience.Catheter Cardiovasc Interv2009;74:148-9

[18] Sellevold OF.Transcutaneous aortic valve implantation: recent advances and future.Curr Opin Anaesthesiol2010;23:67-73

[19] Guarracino F.Con: transcatheter aortic valve implantation should not be performed under general anesthesia.J Cardiothorac Vasc Anesth2012;26:736-9

[20] Motloch LJ,Reda S,Bruns M,Strauch J,Erdmann E,Hoppe UC.Local versus general anesthesia for transfemoral aortic valve implantation.Clin Res Cardiol2012;101:45-53

[21] Brecker SJ,Bosmans J,Tamburino C,Linke A.Impact of anesthesia type on outcomes of transcatheter aortic valve implantation (from the multicenter ADVANCE study).Am J Cardiol2016;117:1332-8

[22] Tritapepe L,Guarracino F,Crivellari M,De Luca M,D'Avolio S,Calabrò MG.Cardiac protection by volatile anaesthetics: a multicentre randomized controlled study in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass.Eur J Anaesthesiol2007;24:323-31

[23] Bignami E,Landoni G,Testa V,Giunta F.Volatile anesthetics reduce mortality in cardiac surgery.J Cardiothorac Vasc Anesth2009;23:594-9

[24] Landoni G,Tritapepe L,Belloni I,Zangrillo A.Cardiac protection by volatile anesthetics.A review. Minerva Anestesiol2009;75:269-73

[25] De Hert SG,Mathur S.Cardioprotection with volatile anesthetics: mechanisms and clinical implications.Anesth Analg2005;100:1584-93

[26] Chiari P,Piriou V.Anaesthetic-induced myocardial preconditioning: fundamental basis and clinical implications.Ann Fr Anesth Reanim2005;24:383-96

[27] Petronio AS,De Carlo M,Colombo A,Klugmann S,Guarracino F,Latib A,Fiorina C,Martina P.Anaesthetic management of transcatheter aortic valve implantation: results from the Italian CoreValve registry.EuroIntervention2016;12:381-8

[28] Goren O,Gluch A,Dery E.Sedation or general anesthesia for patients undergoing transcatheter aortic valve implantation--does it affect outcome? An observational single-center study.J Clin Anesth2015;27:385-90

[29] Wiegerinck EM,Koch KT,Vis MM,Eberl S,Piek JJ,Baan JJr.Towards minimally invasiveness: transcatheter aortic valve implantation under local analgesia exclusively.Int J Cardiol2014;176:1050-2

[30] Piayda KD,Bertog S,Vaskelyte L,Franke J,Staiger N,Sievert H.True first-line local-anesthesia only protocol for transfemoral TAVI.J Invasive Cardiol2015;27:501-8

[31] Durand E,Godin M,Litzler PY,Bejar K,Sanchez-Giron C,Bauer F,Eltchaninoff H.Transfemoral aortic valve replacement with the Edwards SAPIEN and Edwards SAPIEN XT prosthesis using exclusively local anesthesia and fluoroscopic guidance: feasibility and 30-day outcomes.JACC Cardiovasc Interv2012;5:461-7

[32] Yamamoto M,Mouillet G,Monin JL,Dubois-Rande JL.Effect of local anesthetic management with conscious sedation in patients undergoing transcatheter aortic valve implantation.Am J Cardiol2013;111:94-9

[33] Chin D.Echocardiography for transcatheter aortic valve implantation.Eur J Echocardiogr2009;10:i21-9

[34] Gonçalves A,Zamorano JL.Echocardiography: guidance during valve implantation.EuroIntervention2010;6:G14-9

[35] Bufton KA,Cobey FC.Anesthesia for transfemoral aortic valve replacement in North America and Europe.J Cardiothorac Vasc Anesth2013;27:46-9

[36] Park HS,Joung KW,Sim JY.Monitored anesthesia care with dexmedetomidine in transfemoral percutaneous trans-catheter aortic valve implantation: two cases report.Korean J Anesthesiol2014;66:317-21 PMCID:PMC4028562

[37] Dehédin B,Ibrahim H,Provenchère S,Vahanian A,Brochet E,Nataf P,Longrois D.Anesthesia and perioperative management of patients who undergo transfemoral transcatheter aortic valve implantation: an observational study of general versus local/regional anesthesia in 125 consecutive patients.J Cardiothorac Vasc Anesth2011;25:1036-43

[38] Ben-Dor I,Maluenda G,Kambouris NG,Hauville C,Corso PJ,Pichard AD.Transcatheter aortic valve replacement under monitored anesthesia care versus general anesthesia with intubation.Cardiovasc Revasc Med2012;13:207-10

[39] Babaliaros V,Lerakis S,Iturra SA,Leshnower BG,Kanitkar M,Simone A,Ghasemzadeh N,Thourani VH.Comparison of transfemoral transcatheter aortic valve replacement performed in the catheterization laboratory (minimalist approach) versus hybrid operating room (standard approach): outcomes and cost analysis.JACC Cardiovasc Interv2014;7:898-904

[40] Watterson LM,Westhorpe RN.Crisis management during anaesthesia: bradycardia.Qual Saf Health Care2005;14:e9 PMCID:PMC1744007

[41] Morris RW,Westhorpe RN.Crisis management during anaesthesia: hypotension.Qual Saf Health Care2005;14:e11 PMCID:PMC1743997

[42] Abawi M,Agostoni P,de Vries R,Stella PR.Incidence, predictive factors, and effect of delirium after transcatheter aortic valve replacement.JACC Cardiovasc Interv2016;9:160-8

[43] Oguri A,Mouillet G,Laskar M,Fajadet J,Donzeau-Gouge P,Leguerrier A,Lievre M,Dubois-Rande JL,Van Belle E,Teiger E.Clinical outcomes and safety of transfemoral aortic valve implantation under general versus local anesthesia: subanalysis of the French Aortic National CoreValve and Edwards 2 registry.Circ Cardiovasc Interv2014;7:602-10-10

[44] Wöhrle J,Rodewald C,Scharnbeck D.Transfemoral aortic valve implantation with the new Edwards Sapien 3 valve for treatment of severeaortic stenosis-impact of valve size in a single center experience.PLoS One2016;11:e0151247 PMCID:PMC4803290

[45] Kodali S,White J,Lim S,Williams M,Eisenhauer AC,Kereiakes DJ,Babaliaros V,Hahn RT,Weissman NJ,Blanke P,Suri RM,Ayele GM,Webb JG,Smith CR.Early clinical and echocardiographic outcomes after SAPIEN 3 transcatheter aortic valve replacement in inoperable, high-risk and intermediate-risk patients with aortic stenosis.Eur Heart J2016;37:2252-62

[46] Ehret C,Foldenauer AC,Stevanovic A,Hein M.Is local anaesthesia a favourable approach for transcatheter aortic valve implantation? A systematic review and meta-analysis comparing local and general anaesthesia.BMJ Open2017;7:e016321 PMCID:PMC5623571

[47] Gauthier C,Baele P,Kahn D,Momeni M.Mid-term survival after transcatheter aortic valve implantation: results with respect to the anesthetic management and to the access route (transfemoral versus transapical).Ann Card Anaesth2015;18:343-51 PMCID:PMC4881710

[48] Lunardi M,Zivelonghi C,Geremia G,Rossi A,Gottin L,Vassanelli C.Clinical outcomes of transcatheter aortic valve implantation: from learning curve to proficiency.Open Heart2016;3:e000420 PMCID:PMC5013502

[49] Arai T,Hovasse T,Watanabe Y,Benamer H,Cormier B,Morice MC.Evaluation of the learning curve for transcatheter aortic valve implantation via the transfemoral approach.Int J Cardiol2016;203:491-7

[50] Bloomfield GS,Hahn RT,Leipsic J,Tuzcu M.A practical guide to multimodality imaging of transcatheter aortic valve replacement.JACC Cardiovasc Imaging2012;5:441-55

[51] Arora S.Transcatheter aortic valve replacement in intermediate and low risk patients-clinical evidence.Ann Cardiothorac Surg2017;6:493-7 PMCID:PMC5639231

[52] Hamm CW,Mack MJ.The future of transcatheter aortic valve implantation.Eur Heart J2016;37:803-10